An international research team led by the HUG and the UNIGE has shown that amyloid and tau blood-based biomarkers are highly correlated with the corresponding biomarkers used so far for the diagnosis of Alzheimer’s disease. Furthermore, the blood-based biomarkers showed high diagnostic accuracy in discriminating the normal or non-normal status of the amyloid and tau biomarkers.